Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Injective (INJ) vs Lagrange (LA) Price & Performance

InjectiveTrade
LagrangeTrade

Price performance (Past 24H)

Key statistics

Injective vs Lagrange — how do they compare? Injective trades at Rp91,720 (market cap Rp9,15T, Rp1,96T 24h volume), while Lagrange trades at Rp985.32 (market cap Rp190,34M, Rp107,05M 24h volume). The key difference: Injective is far larger — about 48071.9× Lagrange's market cap, and Injective's circulating supply is 100M INJ versus 193M LA for Lagrange. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Lagrange for 7 Days on average.

INJLA
Market Cap
Rp9,15TRp190,34M
Volume (24h)
Rp1,96TRp107,05M
Circulating Supply
100M INJ193M LA
Typical Hold Time
36 Days7 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Injective

Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.

Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.

Lagrange

Lagrange (LA) is currently trading at Rp1,029.31 with a market cap of Rp198.06 million, showing bearish technical signals across most indicators. The token faces significant selling pressure with moving averages indicating strong bearish momentum, though oscillators suggest neutral conditions. Current price sits near resistance at R1 (Rp1,027) with support at S1 (Rp992). No recent protocol updates or ecosystem developments were identified.

Overall outlook remains cautious due to bearish technical structure and limited fundamental catalysts. Key opportunity lies in potential bounce from oversold RSI levels, while major risks include low liquidity and absence of recent development activity. Investors should monitor for any protocol updates that could shift momentum.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INJ
29% Buy71% Sell
Avg holding period · 36 Days
LA
63% Buy37% Sell
Avg holding period · 7 Days

Top news

Latest headlines on both assets

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ

About Lagrange

Lagrange specializes in zero-knowledge proof generation for safe and private AI. Its flagship product, DeepProve, is the fastest zkML system, enabling AI verification through zero-knowledge proofs. Lagrange also offers a decentralized ZK Prover Network for secure, cost-effective proof generation, backed by major validators like Coinbase Cloud and Kraken. Additionally, the SQL-based ZK Coprocessor allows smart contracts to offload complex computations and verify them on-chain.

Read more on LA